Immunosuppressant - PDFSEARCH.IO - Document Search Engine

Immunosuppressant
Results: 22

#	Item
1	Immunosuppressant drug Tacrolimus used in cell transplantation therapy inhibits the nascent construction of vascular network: Towards performance improvement of cell transplantation therapy Professor Masafumi Goto A rese Add to Reading List Source URL: www.med.tohoku.ac.jp Language: English - Date: 2015-01-05 20:01:49 Organ transplants Islets of Langerhans Tacrolimus Sirolimus Immunosuppressive drug Goto Organ transplantation Medicine Immunosuppressants Macrolides
2	Honours Projects 2014 – Pharmacology Transplantation Therapy Project Background The success of kidney transplantation depends largely on preventing rejection of the new organ. A combination of immunosuppressants is us Add to Reading List Source URL: health.adelaide.edu.au Language: English - Date: 2013-09-25 02:05:54 Kidney transplantation Immunosuppressant Organ transplantation Pharmacogenetics Medicine Organ transplants Immunology
3	achanA September 12, 2007 Astellas Initiates Phase II Clinical Trials for Immunosuppressant, ASP0485 Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 20:52:49 Tacrolimus Alefacept Health Psoriasis Transplant rejection Immunosuppressants Medicine Astellas Pharma
4	September 30, 2008 Astellas Submits an sNDA for the immunosuppressant Prograf® for Myasthenia Gravis in Japan Japan, September 30, [removed]Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-30 03:29:44 Immune system Immunosuppressants Macrolides Tacrolimus Myasthenia gravis Astellas Pharma Immunology Quaternary ammonium compounds Systemic lupus erythematosus Anatomy Medicine Autoimmune diseases
5	May 7, 2008 Astellas Receives an Approvable Letter for an Immunosuppressant FK506 Modified Release Formulation in the U.S. Japan, May 7, [removed]Astellas Pharma Inc. (headquarters: Tokyo, President and CEO: Masafumi Nogi Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-17 23:59:47 Immunology Immunosuppressants Macrolides Tacrolimus Astellas Pharma Kidney transplantation Organ transplantation Transplant rejection Allotransplantation Medicine Transplantation medicine Organ transplants
6	June 30, 2006 Astellas Discontinues Development of Immunosuppressant FK778 Japan, June 30, [removed]Astellas Pharma Inc. (Headquarters: Tokyo; President and CEO: Masafumi Nogimori, hereinafter “Astellas”) today announ Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-19 00:55:27 Organ transplants Organ transplantation Medicine Astellas Pharma Tacrolimus
7	March 14, 2008 Astellas Receives an Approvable Letter for Their Immunosuppressant FK506 Modified Release Formulation in the U.S. Japan, March 14, [removed]Astellas Pharma Inc. (headquarters: Tokyo, President and CEO: Masa Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 00:05:39 Tacrolimus Astellas Pharma Kidney transplantation Transplant rejection Medicine Immunosuppressants Macrolides
8	July 17, 2008 Astellas Receives a Japanese Marketing Approval for the Immunosuppressant Graceptor ® Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-17 23:40:21 Immunosuppressants Macrolides Tacrolimus Astellas Pharma Immunology Graft-versus-host disease Liver transplantation Kidney transplantation Organ transplantation Medicine Transplantation medicine Organ transplants
9	May 30, 2006 Application for the immunosuppressant FK506 Modified Release Formulation in Japan Japan, May 30, [removed]Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Toichi Takenaka) today a Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-19 00:58:14 Immunosuppressants Macrolides Tacrolimus Astellas Pharma Graft-versus-host disease Transplant rejection Medicine Transplantation medicine Health
10	June 23, 2008 Submit an sNDA for the immunosuppressant Prograf® for Ulcerative Colitis in Japan Japan, June 23, [removed]Astellas Pharma Inc. (“Astellas”; headquarters: Tokyo; President and CEO: Masafumi Nogimori) to Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-17 23:51:41 Immunosuppressants Macrolides Tacrolimus Astellas Pharma Colitis Autoimmune diseases Ulcerative colitis Intestine Atopic dermatitis Health Medicine Gastroenterology

UPDATE